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Abstract
Background: Although there have been some epide-
miological studies on the effects of diet and nutrition-
al status on cervical carcinogenesis, evidence for a
protective effect of antioxidant micronutrients against
cervical neoplasia is insufficient. The relationship
between serum antioxidant micronutrients and socio-
demographic factors and the risk of cervical neoplasia
was investigated in this multi-center, case-control
study.
Methods: The study population included women with
histopathological diagnosis of cervical intraepithelial
neoplasia (CIN) 1 (ns147), CIN 2/3 (ns177), cervical
cancer (ns160), and a control group (ns378). Epide-
miological data were collected and the serum con-
centrations of b-carotene, lycopene, zeaxanthin plus
lutein, retinol, a-tocopherol, and g-tocopherol were
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measured using reverse-phase, gradient high-pres-
sure liquid chromatography.
Results: Cervical cancer was found to be associated
with older age, increased body mass index, and lower
socioeconomic status as measured by education level
and income. The mean serum concentrations of b-
carotene, lycopene, zeaxanthin plus lutein, retinol,
a-tocopherol, and g-tocopherol of cervical cancer
patients were significantly lower than those of control
subjects. Odds ratio adjusted for age, smoking status,
alcohol consumption, and human papillomavirus
infection status revealed a significant gradient of
decreasing risk of CIN 1, CIN 2/3, and cervical cancer
with increasing serum concentrations of most anti-
oxidant micronutrients.
Conclusions: The results of this study show an inverse
association between serum antioxidant micronutrient
concentrations and the risk of cervical neoplasia.
These results suggest that antioxidant micronutrients
play a role in the prevention of cervical carcino-
genesis.
Clin Chem Lab Med 2009;47:1005–12.
Keywords: antioxidant; cervical cancer; cervical neo-
plasia; micronutrients; sociodemographic factors.
Introduction
Cervical cancer is the second most common cause of
cancer deaths in women worldwide, with ;510,000
new cases and 288,000 deaths occurring globally each
year (1). Research from the last decade has shown
definitively that human papillomavirus (HPV) is the
primary causal agent in cervical carcinogenesis (2).
The recognition of the central role that high risk HPV
plays in the etiology of cervical cancer has led to the
development of a prophylactic vaccination as a new
means of cervical cancer prevention. However, the
impact of this strategy on cervical cancer prevention
is unclear at present. HPV vaccines will reduce, but
not eliminate, the risk of cervical cancer. Screening
programs will continue to be important interventions
for cervical cancer, although the procedures used for
screening may need to be adapted (3).
Cervical cancer associated with HPV infection
results from a continuous process, starting with a nor-
mal cervical epithelium, progressing to intraepithelial
lesions, and finally, invasive cervical cancer. Although
oncogenic HPV infections have been established as a
cause of cervical cancer, most HPV infections are tran-
sient and rarely progress to significant cervical
lesions (4). Epidemiological evidences suggest that
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many HPV cofactors, including antioxidant micro-
nutrients, may alter the natural history of HPV infec-
tion and modulate the progression of HPV infection to
cervical intraepithelial neoplasia (CIN) and invasive
cancer. These cofactors appear to be directly related
to the physiological and immunological state of the
cervix (5).
Nutritional status may be an important cofactor
affecting both persistent HPV infection and progres-
sion to cervical neoplasia (6). Over the past few dec-
ades, a large body of epidemiological evidence
indicates that higher consumption of dietary antioxi-
dants and increased serum concentrations of anti-
oxidant micronutrients may be associated with a
reduced risk of several cancers, including cervical
cancer (7). Antioxidant micronutrients are important
in protecting against oxidative stress, which may
have a role in cancer and cardiovascular diseases (8).
Current research is focused on identifying the asso-
ciation of serum antioxidant micronutrients (b-caro-
tene, lycopene, zeaxanthin plus lutein, retinol,
a-tocopherol, and g-tocopherol) and sociodemogra-
phic factors with the risk of CIN and cervical cancer.
Materials and methods
Subjects recruitment
The data were obtained from a case-control study of cervical
cancer conducted between June 2006 and July 2007 at six
academic medical centers in Korea: Yonsei University Gang-
nam Severance Hospital, National Cancer Center, Korea
University Guro Hospital, Chungnam National University
Hospital, Gachon University Gil Medical Center, Kyunghee
University East-West Neo Medical Center, Ajou University
Medical Center, and The Catholic University of Korea Holy
Family Hospital. The participants for this study were recruit-
ed from women undergoing Papanicolaou (Pap) smear test-
ing and the Hybrid Capture 2 test for screening of cervical
cancer. Eligibility criteria were applied to both cases and
controls and included not being pregnant at the time of
recruitment, having no history of cancer, and having an
intact cervix. After an initial Pap smear, patients with abnor-
mal test results were evaluated with colposcopy. Case sub-
jects comprised those patients who had an abnormal Pap
smear result, colposcopy-directed biopsy, and a histopath-
ological diagnosis of CIN 1, CIN 2/3, or invasive cervical can-
cer. All histological diagnoses were reviewed by two
pathologists. There were 147 CIN 1, 177 CIN 2/3, and 160
cases of invasive cervical cancer in the case group. A total
of 378 control subjects consisted of healthy women who had
no history of an abnormal Pap smear and a normal Pap
smear on the day of recruitment. Less than 5% of cases and
controls offered the chance to participate refused to be inter-
viewed. All patient specimens were collected and archived
using protocols approved by the Institutional Review Boards
(IRBs) of each institution.
Epidemiological data collection
After obtaining informed consent, participants were inter-
viewed by one trained interviewer who was blinded to each
subject’s disease status. Participants completed question-
naires structured to elicit information related to socio-
demographic characteristics, individual medical history, and
family history of cancer. Sociodemographic characteristics
included education, occupation, cigarette smoking, alcohol
consumption, and physical activity, with a detailed time
frame of exposures. Pathology and laboratory data were col-
lected, recorded, and entered into the epidemiological data-
base. Medical charts and pathology reports were examined
to ensure that control subjects had no history of cancer.
Blood sample collection
Twenty mL of peripheral venous blood was obtained after a
period of fasting from each enrolled subject before the ini-
tiation of treatment. Samples were transported to the lab-
oratory without revealing the disease status prior to analysis
of antioxidant micronutrients. All blood samples were cen-
trifuged within 1 h following collection. Following separation
of plasma, samples were stored at –808C until assayed.
High-pressure liquid chromatography analysis
of serum antioxidants
The concentrations of serum carotenoids, retinol, and
tocopherols were measured using high-performance liquid
chromatography (HPLC) (9). Serum samples from study sub-
jects were randomized and analyzed together in the same
batch under subdued light. b-Carotene, lycopene, zeaxan-
thin, lutein, a-tocopherol, and g-tocopherol were purchased
from Sigma Chemical Co. (St. Louis, MO, USA). All solvents
(methanol, ethanol, chloroform, n-hexane, acetonitrile, and
tetrahydrofuran) were purchased from J.T. Baker (Phillips-
burg, NJ, USA) and were filtered through a 0.2-mm mem-
brane filter (Waters, Millipore, MA, USA) before use. Serum
carotenoids, retinol, and tocopherols were extracted using
CHCl3-CH3OH (2:1, v/v). Retinol acetate and tocopherol
acetate were added as internal standards for the analysis of
retinol, carotenoids, and tocopherols. All sample processing
was performed under red light.
To separate the four carotenoids, retinol, and two tocoph-
erols simultaneously, a gradient mobile phase was used. The
detector was set at 292 nm for tocopherols, 340 nm for ret-
inol, and at 450 nm for carotenoids. Individual carotenoids,
retinol, and tocopherols were quantitated using peak areas
calibrated against the standards. Loss due to handling loss
was corrected by measuring the recovery of the internal
standards. Because zeaxanthin and lutein isomers cannot be
separated using the method we employed, they were eluted
together and are hereafter referred to as zeaxanthin plus
lutein. The mean coefficient of variation was 8% for retinol
acetate and tocopherol acetate. Variation between duplicate
serum samples was -1%. The coefficients of variation were
-8% for b-carotene, lycopene, and zeaxanthin plus lutein.
The relative standard deviation (SD) for pooled controls
ranged from 4% to 10%. The concentration of the standard
solution was determined spectrophotometrically using the
extinction coefficient E at 275 nm (E_10–3s14,200). Results
were calculated using the ratio of the peak area of the com-
pound over the peak area of the internal standard.
Statistical analysis
Fisher’s exact test was used to compare the frequency dis-
tributions of categorical demographic variables among the
four groups. Mean values and SDs were calculated as con-
tinuous demographic variables, with the mean differences
tested using ANOVA and Duncan’s multiple comparison. The
geometric mean (95% confidence interval) was calculated for
the serum concentrations of the carotenoids, retinol, and the
tocopherols. ANCOVA was used to compare the mean val-
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Table 1 General characteristics of study subjects.
Variables Control CIN 1 CIN 2/3 Cervical Total
cancer
Age, mean"SD, years 46.8"10.1 40.0"11.3a 40.2"10.1a 51.5"12.2a
BMI, mean"SD, kg/m2 22.8"2.8 22.3"3.1 21.9"3.1a 23.7"3.5b
Education level, n/%
FElementary 48/13 19/13 30/17 60/38 157
Middle school 54/14 12/8 21/12 27/17 114
High school 158/42 59/40 84/47 59/37 360
GUniversity 117/31 56/39 42/24 14/8 229
p-Value 0.181 0.161 -0.0001
Monthly household income, n/%
-1000 US $ 46/13 19/13 22/13 43/31 130
1000–1999 US $ 54/15 25/17 31/18 32/23 142
2000–2999 US $ 62/17 32/22 45/26 25/18 164
3000–3999 US $ 69/19 24/17 41/24 21/15 155
G4000 US $ 130/36 44/31 31/19 18/13 223
p-Value 0.553 0.0007 -0.0001
Cigarette smoking, n/%
Never 343/91 124/84 152/86 140/88 759
Currentd 23/6 16/11 16/9 14/9 69
Formere 12/3 7/5 9/5 6/3 34
p-Value 0.105 0.225 0.495
Passive smokingf, n/%
Mean"SD, min/week, home 455"654 379"590 451"958 372"532
Mean"SD, min/week, workplace 457"996 636"1409 878"1666c 412"1116
Alcohol consumption, n/%
Mean"SD, years 15.9"7.5 12.1"7.6a 12.2"7.0a 16.7"7.8
Ever use oral contraceptive, n/%
No 320/85 116/79 144/81 129/81 709
Yes 58/15 31/21 33/19 30/19 152
p-Value 0.086 0.531 0.569
Ever use multivitamins, n/%
No 194/60 89/69 131/82 113/81 527
Yes 132/40 40/31 28/18 26/19 226
p-Value 0.060 -0.0001 -0.0001
Menopause, n/%
Yes 166/44 32/22 32/18 108/67 338
p-Value -0.0001 -0.0001 -0.0001
Number of childbirth, n/%
1 44/13 11/11 20/14 15/10 90
2 192/58 66/63 90/65 75/51 423
G3 93/28 27/26 29/21 58/39 207
p-Value 0.611 0.247 0.055
Age at menarche, mean"SD, years 14.6"1.8 14.6"2.8 14.5"1.9 15.2"1.7b
Age at 1st delivery, mean"SD, years 25.0"3.9 25.0"3.9 25.4"3.7 23.6"3.4a
ap-0.001. bp-0.01. cp-0.05. dThose who had smoked any type of tobacco within the past 12 months. eThose who had stopped
smoking at least 12 months previously. fThose who frequently stay in rooms where people smoke. Percentage values calcu-
lated only for subjects whose data were available. CIN, cervical intraepithelial neoplasia; BMI, body mass index; SD, standard
deviation.
ues of the serum concentrations of the carotenoids, retinol,
and the tocopherols following log transformation (SAS, SAS
Institute, Inc, Cary, NC, USA) (10), with adjustments for
potential confounders such as age, menopause, parity, oral
contraceptive use, smoking status, alcohol consumption,
and HPV infection status (age as a continuous variable, parity
as a trichotomous variable, and the others as dichotomous
variables).
Results
General characteristics of study subjects
The general characteristics of the study subjects are
presented in Table 1. There were significant differ-
ences between controls and cases with respect to
mean age and mean body mass index (BMI). The mean
age for the controls was 46.8 years, while the mean
ages for the CIN 1, CIN 2/3, and cervical cancer groups
were 40.0, 40.2, and 51.5 years, respectively. The
mean BMI for the controls was 22.8 kg/m2, while the
BMI values for the CIN 1, CIN 2/3, and cervical cancer
groups were 22.3, 21.9, and 23.7 kg/m2, respectively.
There were significant differences between controls
and cases with respect to education level (p-0.0001),
monthly household income (p-0.0001), and meno-
pause status (p-0.0001). There were no significant
differences in active smoking status among the four
study groups, whereas the mean duration of expo-
sure to passive smoke at their place of employment
in CIN 2/3 group was significantly higher than that of
the control group (ps0.009, p-0.05, respectively).
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Table 2 Geometric mean levels of plasma micronutrients of study subjects.
Control CIN 1 CIN 2/3 Cervical cancer Two-sided p
(ns378) (ns147) (ns177) (ns160) for linear trend
Total carotenes, mmol/L 1.30 1.25 1.23 0.99 0.0001
b-Carotene, mmol/L 0.37 0.29 0.30 0.22 -0.0001
Lycopene, mmol/L 0.01 0.009 0.009 0.009 -0.0001
Zeaxanthinqlutein, mmol/L 0.73 0.89 0.85 0.70 0.0021
Retinol, mmol/L 2.17 2.49 2.23 2.12 -0.0001
Total tocopherols, mmol/L 3540 3357 2988 2960 -0.0001
a-Tocopherol, mmol/L 2818 2672 2333 2412 -0.0001
g-Tocopherol, mmol/L 668 640 612 498 -0.0001
CIN, cervical intraepithelial neoplasia.
The mean duration of alcohol consumption, when
compared with that of the controls (15.6
years), was significantly shorter in CIN 1 (12.1 years,
p-0.0001) and CIN 2/3 (12.2 years, p-0.0001)
patients. Also, there were significant differences
between controls and cervical cancer cases in the use
of multivitamins (p-0.0001), mean age at menarche
(p-0.01) and first delivery (p-0.001).
Mean serum concentrations of antioxidant
micronutrients
The mean serum concentrations of antioxidant micro-
nutrients in study subjects are presented in Table 2.
The mean concentrations of b-carotene and lycopene
in CIN 1, CIN 2/3, and cervical cancer patients were
significantly lower than those of controls. Mean
zeaxanthin plus lutein concentrations were signifi-
cantly lower for cervical cancer patients, but higher
for CIN 1 patients compared with controls. The mean
concentration of retinol was significantly higher for
CIN 1 patients. Mean g-tocopherol concentrations
were ;25% of a-tocopherol concentrations in all
study groups, and both tocopherols were significantly
lower in CIN 2/3 and cervical cancer patients com-
pared with controls.
Serum antioxidant micronutrients and risk
of cervical carcinogenesis
Table 3 shows the dose-response relationship
between serum antioxidant micronutrients and the
odds ratio (OR) for CIN 1, CIN 2/3, and cervical cancer
patients following adjustment for age, menopause,
parity, oral contraceptive use, smoking status, alcohol
consumption, and HPV infection status. Approximate-
ly 60% of the case subjects were HPV positive using
the Hybrid Capture 2 tests. We found negative trends
in the OR for CIN 1, CIN 2/3, and cervical cancer asso-
ciated with b-carotene, lycopene, and g-tocopherol.
There were negative trends in the OR for CIN 2/3 and
cervical cancer with respect to a-tocopherol. In con-
trast, the results suggested that higher circulating lev-
els of retinol were associated with a significant
increase in the risk of CIN 1 and CIN 2/3. Higher cir-
culating levels of zeaxanthin plus lutein were associ-
ated with a significant decrease in the risk of cervical
cancer but showed positive trends for CIN 1, despite
the fact that these results were statistically non-
significant.
Discussion
Epidemiological studies show that HPV infection is a
risk factor for the subsequent development of cervical
cancer (11). Women with identified oncogenic types
of genital HPV infections having advanced graded CIN
are considered to have a high risk of developing cer-
vical cancer (12). However, little is known about the
factors or mechanisms that may influence the pro-
gression or spontaneous regression of CIN lesions.
The role of diet and nutrition and risk of HPV per-
sistence and cervical carcinogenesis was recently
reviewed by Garcia-Closas et al. (13). They concluded
that a likely protective effect against cervical neopla-
sia was afforded by folate, retinol, and vitamin E and
possible for vegetables, vitamin C, vitamin B12, a-car-
otene, b-carotene, lycopene, zeaxanthin/lutein, and
cryptoxanthin. In the current study, we report signifi-
cantly decreased serum levels of antioxidant micro-
nutrients, such as b-carotene, lycopene, zeaxanthin
plus lutein, retinol, a-tocopherol, and g-tocopherol in
patients with CIN and cervical cancer.
Our data showed that cervical cancer was associ-
ated with older age, increased BMI, and lower socio-
economic status, as assessed by education and
income. Research in other patient populations has
documented an increased risk of cervical cancer
among women of lower socioeconomic status (14,
15). In our study, women with less than an elementary
school education and an income -$1000 per month
were at increased risk of developing cervical cancer.
These findings imply that interventions designed to
prevent cervical cancer must ensure that all women
of lower socioeconomic status have access to HPV
vaccines, as well as access to education and other
preventive services. Numerous studies have shown a
positive association between oxidative stress meas-
ures and adiposity (16, 17). Also important, serum
vitamin concentrations are progressively lower with
increases in BMI, with the most obese having the
lowest vitamin concentrations (18). Also, our data
showed that increased BMI was associated with
cervical cancer and that BMI was negatively correlat-
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ed with serum concentrations of antioxidant micro-
nutrients.
We found that controls had a tendency to use or
had previously used multivitamins compared with
patients with cervical cancer (40% vs. 19%)
(p-0.0001). Although many studies, including the
Supplementation in Vitamins and Mineral Antioxi-
dants (SU.VI.MAX) study, have failed to demonstrate
the role of antioxidant supplementation in the preven-
tion of cancer (19–21), it is possible that the use of
multivitamins may influence the increased levels of
serum antioxidants in controls. Unlike most previous
research in this field, our study showed that current
cigarette smoking was not related to the risk of cer-
vical cancer, while exposure to passive smoke
seemed to be related to the risk of CIN 2/3. Although
a consistent association between cigarette smoking
and cervical cancer has been noted in numerous stud-
ies (22, 23), the relationship between smoking and
cervical cancer is difficult to prove. This is because of
the strong confounding effect of sexual behavior,
such as number of sexual partners and exposure to
other sexually transmitted diseases. Because the cur-
rent study did not capture this type of information
about potential confounding variables, our findings
could have overestimated or underestimated the risk
of cigarette smoking on development of cervical
neoplasia.
Several studies have suggested a protective effect
of b-carotene against cervical dysplasia, but none of
the findings were statistically significant. In a random-
ized clinical trial investigating the association of
b-carotene with early preinvasive lesions, oral admin-
istration of b-carotene had no effect on atypical
squamous cells of undetermined significance
(ASCUS)-CIN1 regression rates during 2 years of
follow-up (24). Results from a case-control study by
Nagata et al. showed an inverse association between
serum lycopene concentrations and cervical dysplasia
(25). The results of our study support the hypothesis
that increased blood concentrations of several carot-
enoids, especially b-carotene and lycopene, may
decrease the risk of cervical cancer. The risk of cer-
vical cancer was decreased the greatest in women
with high circulating concentrations of b-carotene,
and this relationship was most pronounced in the
subgroups of older women and those who consumed
alcohol (data not shown). We also found that
increased serum concentrations of several carotenes
were associated with a decreased risk of CIN. Zeaxan-
thin plus lutein showed positive trends in the OR for
CIN 1 and CIN 2/3, but there was no statistical
significance.
With respect to retinol, several observational stud-
ies have shown a protective effect of serum retinol
against cervical neoplasia (25, 26). Clinical trials that
have evaluated the effects of topically applied retinoic
acid showed an increase in the regression rates of CIN
2 but not CIN 3, lending support to its efficacy in
patients with early lesions. Our data are inconsistent
with the majority of other studies concerning the
association of serum retinol and risk of cervical dys-
plasia. We found that high serum concentrations of
retinol were associated with an increased risk of CIN
1 and CIN 2/3. However, serum retinol showed a neg-
ative, but non-significant, trend in the OR for cervical
cancer. We suspect that the lack of association
between retinol and cervical dysplasia found in our
study may be due to the small differences in serum
concentrations of retinol observed between controls
and patients with cervical cancer cases, especially
when compared differences seen with the other anti-
oxidant micronutrients.
Few studies have examined the relationship
between serum tocopherols and risk of dysplasia.
Goodman et al. measured serum micronutrient
concentrations and found a significant inverse asso-
ciation between a-tocopherol and risk of cervical
dysplasia after adjustment for HPV and other con-
founders (27). In our studies, high serum concen-
trations of a-tocopherol and g-tocopherol were
associated with reduced risk of CIN and cervical can-
cer, although the relationship between the serum con-
centrations of a-tocopherol and risk of CIN 1 revealed
a marginal inverse correlation. Unfortunately, we
could not compare the corrected tocopherols for
serum lipids because only partial data on blood lipids
were available.
There are possible biological mechanisms by which
micronutrients may protect against the progression of
cervical carcinogenesis. Vitamin C, vitamin E, carote-
noids, and other dietary constituents could act as effi-
cient scavengers of free radicals and oxidants. These
substances, produced during normal metabolism,
inflammatory processes, and also present in high
amounts in tobacco smoke, could lead to extensive
damage of DNA, proteins, and lipids if not neutralized
by antioxidant molecules (28). It has been hypothe-
sized that vitamin C, a-tocopherol, and other antioxi-
dants may reduce the risk of cervical carcinogenesis
by blocking nitrosamine formation from tobacco
smoke (29). Dietary components that possess antiox-
idant properties may protect the immune system
from oxidative damage and enhance immune respon-
siveness (30). Immune cells are particularly vulnera-
ble to oxidative stress. Thus, antioxidant levels in
these cells play an important role in maintaining a
reduced environment and preserving cellular
function.
Our study has potential limitations that must be
considered in the interpretation of our results. First,
recall bias is always a potential problem in case-con-
trol research. To address some of the potential pro-
blems associated with this type of research, we used
a structured interview and a standard protocol for
cases and controls. Second, we collected and meas-
ured the serum concentrations of antioxidant micro-
nutrients at the time of diagnosis. It is possible that
micronutrients may not have the same protective
effects following the genesis of cervical dysplasia. As
sera was not obtained from cases prior to the diag-
nosis of cervical dysplasia, we cannot exclude the
possibility that the observed associations may be a
consequence of disease and not a reflection of the
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etiology the disease. In addition, a single determina-
tion of antioxidant micronutrients at a single point in
time may be a poor indication of long-term dietary
exposure (31). Nevertheless, findings from cohort
studies of blood concentrations of antioxidant micro-
nutrients are generally consistent with the findings
from dietary epidemiological studies. Kardinaal et al.
reported correlation values close to 0.90 for both b-
carotene and a-tocopherol from repeat blood draws
from the same individuals collected 4 months apart
(32). Therefore, analysis of these antioxidant micro-
nutrients from a single blood collection is likely to
classify individuals appropriately in epidemiological
studies. A third potential limitation is that HPV data
were limited to the collection of a single specimen at
study entry. Additional sampling or HPV detection by
polymerase chain reaction (PCR) dot-blot hybridiza-
tion would likely have resulted in a higher proportion
of patients showing HPV infection (33).
Despite these potential limitations, we found
inverse associations between serum antioxidant
micronutrients, especially b-carotene, lycopene, a-
tocopherol, and g-tocopherol, and the development of
cervical neoplasia after adjusting for HPV infection,
cigarette smoking, alcohol consumption, and other
confounders. These results suggest that antioxidant
micronutrients may play a role in the prevention of
cervical carcinogenesis.
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